Orion invests EUR 17 million in its production plants in Turku

NEXT STORY
CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients
PREV STORY
NOHO PARTNERS INTERIM REPORT 1 JANUARY–30 SEPTEMBER 2020: Quick recovery of demand and profitability measures generated operating cash flow of MEUR 5.5 – restrictions weaken the outlook for the remainder of the year
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Worldwide Geographic Information System Industry to 2026 – Asia-Pacific to Register Highest Market Growth

author_avatar
NASDAQ Market News

Bonus BioGroup Receives Approval to Expand Phase-II Clinical Trials for its COVID-19 Treatment to Medical Centers Across Israel

author_avatar
NASDAQ Market News

Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer

author_avatar
NASDAQ Market News